E-LIB Suche - Ergebnisse für: Sucunza, D. (Diego)

1

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Cle..:

Sucunza, Diego ; Rico, Alberto J ; Roda, Elvira...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125775/. , 2021

Link: http://www.ncbi.nlm.nih...

2

Amyloid-Driven Tau Accumulation on Mitochondria Potentially..:

Mar Cuadrado-Tejedor ; Marta Pérez-González ; Rocío Alfaro-Ruiz...
Molecular Neurobiology. , 2021

Link: https://doi.org/10.3390/..

3

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Cle..:

Diego Sucunza ; Alberto J. Rico ; Elvira Roda...
https://www.mdpi.com/1422-0067/22/9/4825. , 2021

Link: https://doi.org/10.3390/..

4

Amyloid-Driven Tau Accumulation on Mitochondria Potentially..:

Cuadrado-Tejedor, Mar ; Pérez-González, Marta ; Alfaro-Ruiz, Rocío...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584544/. , 2021

Link: http://www.ncbi.nlm.nih...

5

Amyloid-Driven Tau Accumulation on Mitochondria Potentially..:

Mar Cuadrado-Tejedor ; Marta Pérez-González ; Rocío Alfaro-Ruiz...
https://www.mdpi.com/1422-0067/22/21/11950. , 2021

Link: https://doi.org/10.3390/..

6

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Cle..:

Diego Sucunza ; Alberto J. Rico ; Elvira Roda...
Molecular Neurobiology. , 2021

Link: https://doi.org/10.3390/..

7

Angiotensin Type 1 Receptor Antagonists Protect Against Alp..:

Rodriguez-Perez, Ana I ; Sucunza, Diego ; Pedrosa, Maria A...
Ministerio de Economía y Competitividad BFU2015-70523. , 2018

Link: https://ddd.uab.cat/reco..

8

Glucocerebrosidase expression patterns in the non-human pri..:

Dopeso-Reyes, I.G. (Iria G.) ; Sucunza, D. (Diego) ; Rico, A.J. (Alberto J.)...
info:eu-repo/grantAgreement/EC/FP7/340527/EU. , 2018

Link: https://hdl.handle.net/1..

9

Angiotensin type 1 receptor antagonists protect against alp..:

Rodriguez-Perez, A.I. (Ana I.) ; Sucunza, D. (Diego) ; Pedrosa, M.A. (Maria A.)...
info:eu-repo/grantAgreement/MINECO/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PI17/00828/ES/ESTUDIO EXPERIMENTAL Y CLINICO PARA IDENTIFICACION DE MARCADORES DE MECANISMOS DE PROGRESION DE LA ENFERMEDAD DE PARKINSON Y POSIBLES DIANAS TERAPEUTICAS PARA NEUROPROTECCION.. , 2018

Link: https://hdl.handle.net/1..

10

Angiotensin type 1 receptor antagonists protect against alp..:

Rodríguez Pérez, Ana Isabel ; Sucunza, Diego ; Pedrosa, María...
Neurotherapeutics, 2018, 15(4). , 2018

Link: http://hdl.handle.net/10..

11

Adeno-associated viral vectors serotype 8 for cell-specific..:

Pignataro, D. (Diego) ; Sucunza, D. (Diego) ; Vanrell, L. (Lucía)...
info:eu-repo/grantAgreement/EC/FP7/340527;286071. , 2017

Link: https://hdl.handle.net/1..

12

Calbindin content and differential vulnerability of midbrai..:

Dopeso-Reyes, I.G. (Iria G.) ; Rico, A.J. (Alberto J.) ; Roda, E. (Elvira)...
https://hdl.handle.net/10171/38340. , 2014

Link: https://hdl.handle.net/1..

13

Calbindin content and differential vulnerability of midbrai..:

Dopeso-Reyes, Iria G ; Rico, Alberto J ; Roda, Elvira...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

14

Amyloid-driven tau accumulation on mitochondria potentially..:

Cuadrado-Tejedor, Mar ; Pérez-González, Marta ; Alfaro-Ruiz, Rocío...
International Journal of Molecular Sciences, 22 (21). ,

Link: https://hdl.handle.net/2..

15

Synthesis and Photophysical Behavior of a Highly Fluorescen..:

Garre Hernández, María Soledad ; Losantos, Raúl ; Gutiérrez Hernández, Sara...
CTQ2017-85263-R and CTQ2017-87372-P (Ministerio de Ciencia, Innovación y Universidades, AEI, FEDER); ISCIII RETIC REDINREN RD16/0009/0015 (Instituto de Salud Carlos III, FEDER). , 2020

Link: http://hdl.handle.net/10..